MedPath

Differences in Coagulation Test Kits

Completed
Conditions
Effect of Different Reagents.
Oral Anticoagulant Therapy
Registration Number
NCT01109667
Lead Sponsor
Yuksek Ihtisas Hospital
Brief Summary

The aim of this study is to assess the effect of Innovin® reagent on laboratory results when compared with the Thromborel® S.

Detailed Description

Thromboplastins are the screening tests which are used in the diagnosis of acquired or inherited disorders of the coagulation system but still, alterations between various thromboplastin preparations in the measurements remains a problem.Blood samples are going to drawn from patients receiving and not receiving oral anticoagulant therapy (OAT) during their routine laboratory tests. Samples are subjected to analysis by using Thromborel® S and Innovin® reagents. Mean International Normalized Ratio (INR), prothrombin time and fibrinogen values are going to compared. To further study the importance of this phenomenon the cohort will be divided into three subgroups according to the INR values as Group I: Patients not receiving OAT, Group II: Patients under OAT and INR values in good therapeutic range and Group III: Patients under OAT and INR values over the therapeutic range.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
350
Inclusion Criteria

Routine control patients receiving and not receiving oral anticoagulant therapy

Exclusion Criteria

Hemolytic and/or lipemic samples were excluded.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Turkiye Yuksek Ihtisas Hospital

🇹🇷

Ankara, Turkey

© Copyright 2025. All Rights Reserved by MedPath